Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/2143
Full metadata record
DC FieldValueLanguage
dc.contributor.authorREG NO:BM0122009-
dc.date.accessioned2026-03-10T07:48:07Z-
dc.date.available2026-03-10T07:48:07Z-
dc.date.issued2025-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/2143-
dc.description.abstractABSTRACT Background: Zinc is essential for growth and neurodevelopment, yet preterm neonates are at risk of deficiency. This randomized controlled trial evaluates the effects of higher-dose zinc supplementation (2 mg/kg/day) versus a lower dose (0.5 mg/kg/day) on growth and neurodevelopment in preterm neonates up to three months corrected gestational age (CGA).en_US
dc.language.isoen_USen_US
dc.publisherKLE Academy of Higher Education and Research, Belagavien_US
dc.subjectZinc, preterm neonates, growth, neurodevelopment, supplementation, RCT.en_US
dc.titleAssessment Of The Effect Of Two Different Doses Of Zinc Supplementation On Neurodevelopment And Growth In Late Preterms : A Hospital Based Randomised Controlled Trialen_US
dc.typeDissertationsen_US
Appears in Collections:Pediatrics MD

Files in This Item:
File Description SizeFormat 
BM0122009.pdf8.4 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.